Overview
Eman Kandeel practices in Cairo, Egypt. Ms. Kandeel is rated as an Experienced expert by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). Her top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Acute Monoblastic Leukemia (AmoL), and Acute Lymphoblastic Leukemia (ALL).
Her clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Chronic Lymphocytic Leukemia (CLL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Ms. Kandeel isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMs. Kandeel isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ms. Kandeel isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Ms. Kandeel isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Promyelocytic LeukemiaMs. Kandeel isExperienced. Learn about Acute Promyelocytic Leukemia.
- Childhood Acute Myeloid LeukemiaMs. Kandeel isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Ms. Kandeel isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Kandeel isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).